Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring

Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring

This manuscript summarizes the results of the consensus meeting composed of hematologists and cardiologists to establish recommendations for the prevention and follow-up of cardiovascular (CV) risk in patients with chronic myeloid leukemia (CML) treated with BCR-ABL tyrosine kinase inhibitors (TKIs)...

Full description

Bibliographic Details
Main Authors: Fernanda Salles Seguro, Carolina Maria Pinto Domingues Carvalho Silva, Carla Maria Boquimpani de Moura, Monika Conchon, Laura Fogliatto, Vaneuza Araujo Moreira Funke, André Abdo, Ariane Vieira Scarlatelli Macedo, Marilia Harumi Higushi dos Santos, José Francisco Kerr Saraiva
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Cardiovascular diseases
Leukemia, myeloid
Protein kinase inhibitors
Risk factors
Risk management
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920300766

Internet

http://www.sciencedirect.com/science/article/pii/S2531137920300766

Similar Items